A Resolution requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2017
Committee Review
Floor Vote
Governor
Introduced Jan 23, 2017
Last action Sep 13, 2018
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
15
Key actions
1
Committee
2
May 8, 2017
Lower · Passed
Reported as committed
lower
Jan 25, 2017
Committee
Referred to HUMAN SERVICES
lower
Jan 23, 2017
Introduced
PN 0020 INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35
lower
1 primary · 13 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Frank Burns
DDemocratic
Co
Bob Freeman
DDemocratic
Co
Dan Deasy
DDemocratic
Co
Dan Moul
RRepublican
Co
David R. Millard
RRepublican
Co
Ed Gainey
DDemocratic
Co
Ed Neilson
DDemocratic
Co
Eddie Pashinski
DDemocratic
Co
Frank Farry
RRepublican
Co
Harry Readshaw
DDemocratic
Co
Katharine M. Watson
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 17
Scope: PA
Hi! I can help you understand HR 17. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline